BLYSVIA

Transdermal patches; adhesive skin patches for medical use; transdermal and adhesive skin patches for treating, alleviating or preventing the development or progression of allergies or immunological disorders; transdermal and adhesive skin patches for the transdermal delivery of pharmaceuticals or medical preparations; patches or epicutaneous systems for cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating allergies or immunological disorders; adhesive patches or adhesive epicutaneous systems for cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating allergies or immunological disorders; occlusive patches or occlusive epicutaneous systems for cutaneous or epicutaneous administration of powdered medical or pharmaceutical substances for treating allergies or immunological disorders; patches or epicutaneous systems containing a powdered preparation for medical or pharmaceutical use for treating allergies or immunological disorders; patches or epicutaneous systems for use in the treatment of allergies or immunological disorders; patches or epicutaneous systems featuring allergens or antigens for treating allergies or immunological disorders; allergy medication; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating food allergies; parts and fittings for the aforesaid goods

Pads and skin patches for medical training purposes; pads and skin patches for medical use, namely for use in training medical professionals on the transdermal delivery of pharmaceuticals or medical preparations; parts and fittings for all the aforesaid goods